User login
Zinc nasal gel effective for the common cold
Zinc nasal gel (Zicam) reduced the duration of the common cold by 41 hours, was well tolerated, and was relatively inexpensive.
More studies, in a broader population, comparing zinc nasal gel with other cold remedies (such as decongestants, antihistamines, antitussives, and antipyretics/analgesics) are needed before recommending it as first-line therapy.
Zinc nasal gel (Zicam) reduced the duration of the common cold by 41 hours, was well tolerated, and was relatively inexpensive.
More studies, in a broader population, comparing zinc nasal gel with other cold remedies (such as decongestants, antihistamines, antitussives, and antipyretics/analgesics) are needed before recommending it as first-line therapy.
Zinc nasal gel (Zicam) reduced the duration of the common cold by 41 hours, was well tolerated, and was relatively inexpensive.
More studies, in a broader population, comparing zinc nasal gel with other cold remedies (such as decongestants, antihistamines, antitussives, and antipyretics/analgesics) are needed before recommending it as first-line therapy.
Comparing celecoxib with traditional nonsteroidal anti-inflammatory drugs
Celecoxib is as effective as other nonsteroidal anti-inflammatory drugs (NSAIDs) for treating the symptoms of osteoarthritis or rheumatoid arthritis. However, patients taking celecoxib are less likely to discontinue the medication because of gastrointestinal upset than patients taking traditional NSAIDs. Nevertheless, celecoxib does not decrease the incidence of serious gastrointestinal adverse events with long-term therapy.
Celecoxib is as effective as other nonsteroidal anti-inflammatory drugs (NSAIDs) for treating the symptoms of osteoarthritis or rheumatoid arthritis. However, patients taking celecoxib are less likely to discontinue the medication because of gastrointestinal upset than patients taking traditional NSAIDs. Nevertheless, celecoxib does not decrease the incidence of serious gastrointestinal adverse events with long-term therapy.
Celecoxib is as effective as other nonsteroidal anti-inflammatory drugs (NSAIDs) for treating the symptoms of osteoarthritis or rheumatoid arthritis. However, patients taking celecoxib are less likely to discontinue the medication because of gastrointestinal upset than patients taking traditional NSAIDs. Nevertheless, celecoxib does not decrease the incidence of serious gastrointestinal adverse events with long-term therapy.